Product Information

GABAPENTIN 400 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0428 per EA under NDC 16571086901. Its NADAC has been published 207 times since Nov 30, 2022.

FDA first approved this application on Mar 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 400 MG CAPSULE

gabapentin
$0.0428per EA

Strength

400 mg/1

NDC

16571086901

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA207099

FDA Approved

3/24/2017

TE Code

AB

On Market Since

8/1/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 400 MG CAPSULE has been published 207 times since Nov 30, 2022, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0428 per EA
All-time high$0.0607 (Oct 11, 2023)
All-time low$0.0396 (Apr 22, 2026)
52-week high$0.0428
52-week low$0.0396
Median price$0.0471
Average price$0.0485
Largest weekly change+23.4% (Aug 21, 2024)
Weeks tracked207
Tracking sinceNov 30, 2022

Price History

1W

0.0%

1M

+1.5%

3M

+5.5%

6M

+8.2%

1Y

+2.7%

3Y

-21.3%

5Y

N/A

All

-25.0%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 400 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0428 per EA (NDC 16571086901), effective Nov 11, 2026.

How has the price of GABAPENTIN 400 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 25.0%. It has been tracked across 207 weekly CMS publications since Nov 30, 2022.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?

Since Nov 30, 2022, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.0607 (Oct 11, 2023), with a median of $0.0471 per EA.

Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 400 MG CAPSULE, is $0.0400 per EA — about 7% below GABAPENTIN 400 MG CAPSULE.

Who manufactures GABAPENTIN 400 MG CAPSULE?

GABAPENTIN 400 MG CAPSULE (NDC 16571086901) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.